MedTrace Logo

Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables

NCT05208541 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-01-26

No results posted yet for this study

Summary

ADHOC-LA is an observational study of people living with HIV who either are taking, or have taken, a long-acting injectable therapy to manage their HIV. Data from this study will be used to research the ways in which HIV impacts the lives of these patients.

Conditions

Sponsors & Collaborators

  • AIDS Healthcare Foundation

    collaborator OTHER

  • Be Well Medical Center

    collaborator UNKNOWN

  • Central Texas Clinical Research

    collaborator UNKNOWN

  • The Crofoot Research Center, Inc.

    collaborator INDUSTRY

  • Gary J. Richmond, MD

    collaborator UNKNOWN

  • Hennepin County Medical Center, Minneapolis

    collaborator OTHER

  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER

  • Infectious Diseases Association of Central VA

    collaborator UNKNOWN

  • KC Care Health Center

    collaborator UNKNOWN

  • Long Beach Education and Research Consultants

    collaborator UNKNOWN

  • Mills Clinical Research

    collaborator INDUSTRY

  • North Texas Infectious Disease Consultants

    collaborator UNKNOWN

  • Felizarta, Franco, M.D.

    collaborator INDIV

  • Prism Health North Texas

    collaborator OTHER

  • Texas Centers for Infectious Disease Associates

    collaborator UNKNOWN

  • ViiV Healthcare

    collaborator INDUSTRY

  • Mazonson & Santas Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-20
Primary Completion
2026-05-20
Completion
2026-05-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05208541 on ClinicalTrials.gov